SEC Form 4 · accession 0001019056-18-000441
Aptevo Therapeutics Inc. · APVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marvin L White
Officer — President and CEO · Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001671584
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F1 | $3.13 | Mar 9, 2018 | A | 151,600 | A | — | Mar 9, 2028 | Common Stock | 151,600 | 151,600 | D |
Explanation of responses
- F1On March 9, 2018, the reporting person was granted 151,600 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date.